Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Francesco Amenta"'
Autor:
Vania Karami, Andrea Romano, Filippo Carducci, Antonio Ivano Triggiani, Flavio Nobili, Maria Teresa Pascarelli, Franco Giubilei, Giovanni B. Frisoni, Alessandro Bozzao, Giuseppe Noce, Andrea Soricelli, Claudio Babiloni, Luca Patané, Raffaele Ferri, Fabrizio Stocchi, Francesco Amenta, Paolo Arena, Claudio Del Percio, Roberta Lizio
Publikováno v:
Clinical Neurophysiology. 132:232-245
Objective This retrospective and exploratory study tested the accuracy of artificial neural networks (ANNs) at detecting Alzheimer’s disease patients with dementia (ADD) based on input variables extracted from resting-state electroencephalogram (rs
Autor:
Francesco Amenta, E. Espinosa, Felicia Gurău, Francesco Prattichizzo, Angelica Giuliani, Armanda Pugnaloni, Simone Baldoni, Jacopo Sabbatinelli, Maria Rita Rippo, Massimiliano Bonafè, Giulia Matacchione, Andrea Silvestrini, Antonio Domenico Procopio, Fabiola Olivieri
Publikováno v:
Ageing Research Reviews. 61:101074
Epidemiological evidence from observational studies suggests that dietary polyphenols (PPs) – phytochemicals found in a variety of plant-based foods – can reduce the risk of developing type 2 diabetes mellitus (T2DM). Clinical trials have also in
Autor:
Claudio Babiloni, Maria Teresa Pascarelli, Marina Blūma, Giuseppe Noce, Vania Karami, Roberta Lizio, Francesco Amenta, Claudio Del Percio
Publikováno v:
Clinical Neurophysiology. 130:e86-e87
Background This retrospective study aimed to check whether the resting state eyes-closed electroencephalographic (rsEEG) rhythms might reflect brain arousal in patients with Alzheimer’s disease dementia (ADD) at the group and the individual level.
Autor:
Laura Serafina Cerasa, Daniele Tomassoni, Piera Sozio, Francesco Amenta, Seyed Khosrow Tayebati, Antonio Di Stefano
Publikováno v:
Journal of the Neurological Sciences. 302:49-57
The influence of one week treatment with the choline-containing phospholipids cytidine-5'-diphosphocholine (CDP-choline) and choline alphoscerate (L-alpha-glyceryl-phosphorylcholine) at choline-equivalent doses (CDP-choline: 325 mg/kg/day; choline al
Autor:
Daniele Tomassoni, Enea Traini, Francesco Amenta, Fiorenzo Mignini, Giorgio Silvestrelli, Alessia Lanari
Publikováno v:
Journal of the Neurological Sciences. 283:219-223
Nicardipine is a dihydropyridine-type Ca(2+) channel blocker (CCB) with strong antihypertensive activity and with a peculiar cerebrovascular profile. This paper has reviewed the main controlled clinical studies on nicardipine in pathologies associate
Publikováno v:
Journal of the Neurological Sciences. :147-151
Hypertension is a risk factor for stroke and may also contribute to the development of vascular cognitive impairment (VCI) and vascular dementia (VaD). Cognitive complications of hypertension and the influence of anti-hypertensive treatment were unde
Autor:
Francesco Amenta, Salvatore Mariotta, Elena Bronzetti, Alberto Ricci, Seyed Khosrow Tayebati, Mannino F
Publikováno v:
Journal of Neuroimmunology. 129:178-185
The expression of muscarinic cholinergic receptor subtypes was investigated in peripheral blood lymphocytes (PBL) of bronchial asthma patients by a combined kinetic and equilibrium labeling technique for radioligand binding assay of muscarinic cholin
Autor:
Francesco Amenta, Damiano Zaccheo, Alberto Ricci, Elena Bronzetti, Seyed Khosrow Tayebati, Fiorenzo Mignini
Publikováno v:
Journal of Neuroimmunology. 96:234-240
Molecular biology studies have shown that human peripheral blood lymphocytes express a dopamine D5 receptor, whereas no information is available on dopamine D receptor, the other dopamine D1-like receptor subtype. Radioligand binding assay investigat
Publikováno v:
Journal of Neuroimmunology. 92:191-195
Molecular biology studies have demonstrated that human peripheral blood lymphocytes express dopamine D 2 -like receptors belonging to the D 3 and D 4 receptor subtypes, whereas the characterization of these receptors using radioligand binding assay t
Publikováno v:
Journal of the neurological sciences. 283(1-2)
The present study was designed to assess if treatment with acetylcholinesterase inhibitor galantamine and the cholinergic precursor choline alphoscerate (alpha-glyceryl-phosphoryl-choline) alone or in association has any protective effect on brain mi